About Alliance Pharma plc (LON:APH)
Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.
Industry, Sector and Symbol:
- Market Cap: £279.01 million
- Outstanding Shares: 472,899,000
- 50 Day Moving Avg: GBX 54.59
- 200 Day Moving Avg: GBX 52.01
- 52 Week Range: GBX 41.33 - GBX 60
Sales & Book Value:
- Trailing P/E Ratio: 12.83
- P/E Growth: 0.00
- Annual Revenue: £101.43 million
- Price / Sales: 2.75
- Book Value: GBX 0.40 per share
- Price / Book: 1.48
- EBITDA: £26.4 million
- Net Margins: 26.73%
- Return on Equity: 14.63%
- Return on Assets: 8.39%
- Average Volume: 727,635 shs.
Frequently Asked Questions for Alliance Pharma plc (LON:APH)
What is Alliance Pharma plc's stock symbol?
Alliance Pharma plc trades on the London Stock Exchange (LON) under the ticker symbol "APH."
How often does Alliance Pharma plc pay dividends? What is the dividend yield for Alliance Pharma plc?
Alliance Pharma plc declared a dividend on Wednesday, September 13th. Investors of record on Thursday, December 21st will be given a dividend of GBX 0.44 per share on Thursday, January 11th. This represents a yield of 0.84%. The ex-dividend date is Thursday, December 21st. The official announcement can be seen at this link. View Alliance Pharma plc's Dividend History.
Where is Alliance Pharma plc's stock going? Where will Alliance Pharma plc's stock price be in 2017?
3 brokerages have issued 12-month price objectives for Alliance Pharma plc's shares. Their forecasts range from GBX 58 to GBX 60. On average, they expect Alliance Pharma plc's share price to reach GBX 59 in the next twelve months. View Analyst Ratings for Alliance Pharma plc.
Who are some of Alliance Pharma plc's key competitors?
Some companies that are related to Alliance Pharma plc include Consort Medical plc (CSRT), STAAR Surgical Company (STAA), TG Therapeutics (TGTX), NantHealth (NH), Transenterix (TRXC), Transenterix (TRXC), Hanger (HGR), Georgia Healthcare Group PLC (GHG), Medical Facilities Corp (DR), InVitae Corp (NVTA), Eco Animal Health Group Plc (EAH), Craneware plc (CRW), R1 RCM (RCM), Cambian Group PLC (CMBN), SIGA Technologies (SIGA), BioTime (BTX), Senseonics Holdings (SENS) and Puretech Health PLC (PRTC).
Who are Alliance Pharma plc's key executives?
Alliance Pharma plc's management team includes the folowing people:
- John Dawson, Chief Executive Officer, Executive Director
- Andrew Franklin, Finance Director, Director
- Peter Butterfield, Chief Commercial Officer, Executive Director
- Janice Timberlake, Director of Human Resources
- Margaret Boulton, Medical and Regulatory Affairs Director
- Stephen Kidner, Operations Director
- Dan Thomas, Business Development Director
- Sarah Robinson, Company Secretary
- Andrew L. Smith, Non-Executive Chairman of the Board
- Thomas Theodore Casdagli, Non-Executive Director
How do I buy Alliance Pharma plc stock?
Shares of Alliance Pharma plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Alliance Pharma plc's stock price today?
MarketBeat Community Rating for Alliance Pharma plc (LON APH)MarketBeat's community ratings are surveys of what our community members think about Alliance Pharma plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Alliance Pharma plc stock can currently be purchased for approximately GBX 59.
Earnings History for Alliance Pharma plc (LON:APH)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Alliance Pharma plc (LON:APH)
Current Year EPS Consensus Estimate: $4.00 EPS
Dividend History by Quarter for Alliance Pharma plc (LON APH)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Alliance Pharma plc (LON:APH)Insider Trades by Quarter for Alliance Pharma plc (LON:APH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|2/14/2017||Peter Butterfield||Insider||Sell||61,846||GBX 49||£30,304.54|
|9/22/2016||John Dawson||Insider||Sell||3,000,000||GBX 45||£1,350,000|
|12/17/2015||Smith,Andrew L||Insider||Buy||75,000||GBX 41||£30,750|
|6/16/2015||Nigel Clifford||Insider||Buy||58,227||GBX 39.50||£22,999.67|
Headline Trends for Alliance Pharma plc (LON:APH)
Latest Headlines for Alliance Pharma plc (LON:APH)
Alliance Pharma plc (APH) Chart for Friday, October, 20, 2017